Ads
related to: atropine eye drop for myopia
Search results
Results From The WOW.Com Content Network
Vyluma is a clinical-stage biopharmaceutical company with a focus on pharmaceutical treatments for refractive errors of the eye. Vyluma’s pipeline of therapies is led by NVK002, an investigational, preservative-free, low-dose atropine eye drop to treat the progression of myopia in children aged 3 years and older.
Another way of preventing myopia progression includes using low-dose atropine eye drops, which are typically used to help dilate pupils during an eye exam, according to HealthyChildren.org.
Topical atropine is used as a cycloplegic, to temporarily paralyze the accommodation reflex, and as a mydriatic, to dilate the pupils. [15] Atropine degrades slowly, typically wearing off in 7 to 14 days, so it is generally used as a therapeutic mydriatic, whereas tropicamide (a shorter-acting cholinergic antagonist) or phenylephrine (an α-adrenergic agonist) is preferred as an aid to ...
Cyclopentolate, Atropine, Tropicamide, and Homatropine are the typical cycloplegic eye drops used once daily to treat spasm of accommodation by relaxing the ciliary muscle. One side effect is blurred vision since these induce dilation.
A diagnosis of myopia is typically made by an eye care professional, usually an optometrist or ophthalmologist. This is by refracting the eye with the use of cycloplegics such as atropine with responses recorded when accommodation is relaxed. [12] Diagnosis of progressive myopia requires regular eye examination using the same method. [12]
While it's not technically an eye drop product, implicated tubes of ointment (which is used on skin in proximity to the eye) can be identified with the NDC 72570-122-35 and UPC code 3 72570 12235 3.